145123-24-6

Basic information

• Product Name: 2-AMino-3-broMobenzaldehyde
• Synonyms: 2-AMino-3-broMobenzaldehyde
• CAS NO: 145123-24-6
• Molecular Formula: C₇H₆BrNO
• Molecular Weight: 200.03264
• Mol File: 145123-24-6.mol
• Article Data: 13

Chemical Properties

• Melting Point: 40℃
• Boiling Point: 291.4±25.0 °C(Predicted)
• Appearance: /
• Density: 1.672±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: -1.70±0.10(Predicted)
• CAS DataBase Reference: 2-AMino-3-broMobenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMino-3-broMobenzaldehyde(145123-24-6)
• EPA Substance Registry System: 2-AMino-3-broMobenzaldehyde(145123-24-6)

Safety Data

• Hazardous Substances Data: 145123-24-6(Hazardous Substances Data)

Usage

General Description

2-Amino-3-bromobenzaldehyde is an organic compound with the chemical formula C7H7BrNO. It is a pale yellow solid that is used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and dyes. The compound contains an amino group and a bromine atom attached to a benzene ring, as well as an aldehyde functional group. It is primarily used as a building block for the production of various organic compounds and can undergo a variety of chemical reactions, including halogenation, condensation, and substitution reactions. 2-Amino-3-bromobenzaldehyde is also used as a reagent in organic synthesis and as a precursor for the preparation of heterocyclic compounds. It should be handled and stored with proper safety precautions due to its potential hazards as a chemical compound.

Upstream product

• 114344-60-4 2-amino-3-bromo-benzonitrile 
• 882772-99-8 3-bromo-2-nitrobenzaldehyde 
• 20776-51-6 2-amino-3-bromo benzoic acid 
• 397323-70-5 (2-amino-3-bromophenyl)methanol 
• 67-68-5 dimethyl sulfoxide 
• 615-36-1 2-bromoaniline 

Relevant articles and documents

Light-Driven Proton Reduction in Aqueous Medium Catalyzed by a Family of Cobalt Complexes with Tetradentate Polypyridine-Type Ligands

A series of tetradentate 2,2′:6′,2″:6″,2″-quaterpyridine-type ligands related to ppq (ppq = 8-(1″,10″-phenanthrol-2″-yl)-2-(pyrid-2′-yl)quinoline) have been synthesized. One ligand replaces the 1,10-phenanthroline (phen) moiety of ppq with 2,2′-bipyridine and the other two ligands have a 3,3′-polymethylene subunit bridging the quinoline and pyridine. The structural result is that both the planarity and flexibility of the ligand are modified. Co(II) complexes are prepared and characterized by ultraviolet-visible light (UV-vis) and mass spectroscopy, cyclic voltammetry, and X-ray analysis. The light-driven H2-evolving activity of these Co complexes was evaluated under homogeneous aqueous conditions using [Ru(bpy)3]2+ as the photosensitizer, ascorbic acid as a sacrificial electron donor, and a blue light-emitting diode (LED) as the light source. At pH 4.5, all three complexes plus [Co(ppq)Cl2] showed the fastest rate, with the dimethylene-bridged system giving the highest turnover frequency (2125 h-1). Cyclic voltammograms showed a significant catalytic current for H2 production in both aqueous buffer and H2O/DMF medium. Combined experimental and theoretical study suggest a formal Co(II)-hydride species as a key intermediate that triggers H2 generation. Spin density analysis shows involvement of the tetradentate ligand in the redox sequence from the initial Co(II) state to the Co(II)-hydride intermediate. How the ligand scaffold influences the catalytic activity and stability of catalysts is discussed, in terms of the rigidity and differences in conjugation for this series of ligands. (Chemical Equation Presented).

2 - Formyl quinoline carboxamide compound and medical application thereof

The invention relates to 2 - formyl quinoline carboxamide compound and medical application thereof, and the structure is shown in a formula (I). The invention further relates to a preparation method of the compound. Use of a pharmaceutical composition and

COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of adenosine or adenosine receptor related disorders.

Asymmetric synthesis of isoquinolinonaphthyridines catalyzed by a chiral Br?nsted acid

A catalytic asymmetric method for the synthesis of chiral isoquinolinonaphthyridines has been developed. A chiral disulfonimide catalyzes a redox cyclization reaction between 2-methyl-3-aldehydeazaarenes and 1,2,3,4-tetrahydroisoquinolines to deliver a range of isoquinolinonaphthyridines with good to high yields (up to 91%) and up to 92:8 er.